NL-OMON32961
Recruiting
Phase 4
discontinuation of combination antipsychotics to monotherapy: risk or added value? - ACiS (Antipsychotic Combinations in Schizophrenia)
Symforagroep (Amersfoort)0 sites160 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- psychosis
- Sponsor
- Symforagroep (Amersfoort)
- Enrollment
- 160
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with schizophrenia. Diagnosis is determined by the MINI Plus (van Vliet and the Fair 2007\)
- •Patients treated with both first\-and half\-generation antipsychotic
- •Age 18 \-70 years
- •Each patient needs to agree with the study procedures.
- •Patients agree with the tests and examinations specified in the protocol.
- •Each patient should understand the purpose of the study and sign the informed consent document.
Exclusion Criteria
- •High risk of relapse with aggression.
- •Serious illness other than schizophrenia, eg liver, kidney or gastrointestinal disorders, for which hospitalization is required within 9 months or leading to death within 3 years.
- •Severe suicidality.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?NL-OMON55806Erasmus MC, Universitair Medisch Centrum Rotterdam122
Active, not recruiting
Phase 1
Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?People with challenging behavior and off-label antipsychotic useTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2016-002859-19-NLErasmus MC
Active, not recruiting
Not Applicable
Deprescribing of antipsychotics of patients with dementia in long term care - an intervention studyF03Unspecified dementiaDRKS00017831Medizinische Fakultät der TU München, Klinik und Poliklinik für Psychiatrie und Psychotherapie32
Active, not recruiting
Phase 1
RADAR TrialSchizophrenia, delusional disorders, schizoaffective disorder, psychosisMedDRA version: 20.0Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: HLTClassification code 10012256Term: Delusional disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10039621Term: Schizoaffective disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: LLTClassification code 10037234Term: PsychosisSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]EUCTR2016-000709-36-GBC402
Active, not recruiting
Not Applicable
Seponering av antipsykotika og antidepressiva hos demente pasienter med APSD i sykehjem - en åpen studie.The included patients are all elderly people with dementia of Alzheimer or vascular type. Their dementia is moderate or severe and they all have Behavioral or Psychological Symptomes (BPSD).MedDRA version: 8.1Level: LLTClassification code 10057678Term: Vascular dementiaEUCTR2006-000287-84-NOSykehuset Innlandet HF24